The Global Programme to Eliminate Lymphatic Filariasis: History and achievements with special reference to annual single-dose treatment with diethylcarbamazine in Samoa and Fiji
Diethylcarbamazine (DEC), first introduced in 1947, was shown to have strong efficacy and safety for treatment of human lymphatic filariasis, which is caused mostly by a species Wuchereria bancrofti. Many studies to optimize the dosage and treatment schedule of DEC followed, and, based on the result...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Japanese Society of Tropical Medicine
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191775/ |